- Seven deaths in UK among AstraZeneca jab recipients after blood clots: medical regulator
Seven Deaths In UK Among AstraZeneca Jab Recipients After Blood Clots: Medical Regulator
The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died
London, (APP - UrduPoint / Pakistan Point News - 3rd Apr, 2021 ) :The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
The British acknowledgement of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement that "Out of the 30 reports up to and including 24 March, sadly 7 have died." The reports of thrombosis, submitted by medics or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country.
Most of the cases (22) were a rare clotting condition called cerebral venous sinus thrombosis. Eight cases saw people suffer other types of thrombosis combined with low levels of blood platelets, which help blood clot.
But MHRA chief executive Dr June Raine stressed that the benefits far outweighed any risks. "The public should continue to get their vaccine when invited to do so," she said.
It said Wednesday that there had been 62 cases worldwide of cerebral venous sinus thrombosis, 44 of them in the European Economic Area, which includes the European Union, Iceland, Liechtenstein and Norway.
More than 9.2 million AstraZeneca jabs have been administered in the region.
The EMA said it believes the vaccine is safe and that experts have found no specific risk factors such as age, gender or medical history.
- 'Weight of evidence' - Paul Hunter, a medical microbiologist at Britain's University of East Anglia, told AFP that he had initially thought the link between vaccination and blood clots was likely to be a "random association".
As evidence mounts of clusters in separate countries, "the weight of evidence is now looking towards Oxford-AstraZeneca actually being the cause of these adverse events", he said.
Nevertheless, the risk for the unvaccinated of dying from Covid is "substantially greater," he said.
A spokeswoman for AstraZeneca told AFP that patient safety is its "highest priority".
AstraZeneca said last month following US efficiency trials that its vaccine is 76 percent effective at preventing the disease. It also said data for the EU and the UK showed no increased risk of blood clots.